Hyaluronic Acid Sodium Salt and Hydeal-D in the Management of LUTS After TURBT for NMIBC.

NATerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

December 22, 2022

Study Completion Date

December 22, 2022

Conditions
Non-muscle Invasive Bladder Cancer (NMIBC)
Interventions
DEVICE

Hyaluronic Acid (HA) sodium salt and Hydeal-D

intravesical solution containing Hyaluronic Acid (HA) sodium salt and Hydeal-D

Trial Locations (1)

20089

Humanitas Research Hospital, Rozzano

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY